Pittet, V; Juillerat, P; Michetti, P; Vader, J-P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J-J; Froehlich, F; Swiss IBD Cohort Study Group, The (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary pharmacology & therapeutics, 32(8), pp. 1007-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04434.x
Full text not available from this repository. (Request a copy)About 30-50% of patients with Crohn's disease (CD) develop fistulae, implying significant disease burden and complicated clinical management.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology 04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Seibold, Frank Werner |
ISSN: |
0269-2813 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:10 |
Last Modified: |
05 Dec 2022 14:01 |
Publisher DOI: |
10.1111/j.1365-2036.2010.04434.x |
PubMed ID: |
20937046 |
Web of Science ID: |
000282221200007 |
Additional Information: |
Christoph Müller (Institute of Pathology) is Member of the Swiss IBD Cohort Study Group |
URI: |
https://boris.unibe.ch/id/eprint/1489 (FactScience: 203172) |
Actions (login required)
 |
Edit item |